Bloomage BioTechnology Corporation Limited (SHA:688363)

SHA:688363 Financials Overview

Financials in millions CNY. Fiscal year is January - December.

Revenue & Profits

Chart

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Revenue Revenue Growth	3,695	4,199	5,371	6,076	6,359	4,948
Revenue Growth	-23.36%	-21.82%	-11.61%	-4.45%	28.53%	87.93%
Gross Profit Gross Profit Growth	2,435	2,847	3,889	4,417	4,877	3,829
Operating Income Operating Income Growth	77.72	235.23	232.36	570.18	961.48	746.46
Net Income Net Income Growth	224	292.06	174.27	592.56	970.92	782.33
Earnings Per Share EPS Growth	0.47	0.61	0.36	1.23	2.01	1.62
EPS Growth	325.10%	69.44%	-70.73%	-38.81%	24.07%	20.00%

Revenue by Geography

Chart

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Hong Kong Hong Kong Growth	60.21	48.9	54.52	35.3	27.96
Mainland China Mainland China Growth	5,258	6,646	7,555	8,565	6,465
Offset Offset Growth	-1,522	-1,690	-1,955	-2,603	-2,125
Other Countries or Regions Other Countries or Regions Growth	402.77	366.16	420.91	361.49	579.43
Total Total Growth	4,199	5,371	6,075	6,359	4,947

Cash & Debt

Chart

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Investments Cash & Investments Growth	1,148	1,028	749.29	1,309	2,137	2,654
Total Debt Total Debt Growth	482.21	341.38	359.69	208.1	389.79	300.01
Net Cash (Debt) Net Cash Growth	665.4	686.9	389.6	1,101	1,747	2,354
Net Cash Growth	22.57%	76.31%	-64.60%	-37.00%	-25.77%	12.67%
Net Cash Per Share Net Cash Per Share Growth	1.39	1.43	0.80	2.28	3.62	4.87

Cash Flow & CapEx

Chart

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Operating Cash Flow Operating Cash Flow Growth	933.29	627.45	564.51	699.65	635.19	1,276
Capital Expenditures CapEx Growth	-348.01	-325.68	-721.39	-1,030	-696.41	-784.21
Free Cash Flow Free Cash Flow Growth	585.28	301.77	-156.88	-330.68	-61.22	491.85
Free Cash Flow Growth	468.13%	-	-	-	-	-

Margins

Chart

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Gross Margin	65.91%	67.80%	72.41%	72.69%	76.69%	77.40%
Operating Margin	2.10%	5.60%	4.33%	9.38%	15.12%	15.09%
Pretax Margin	6.11%	7.95%	3.97%	11.55%	17.87%	17.99%
Profit Margin	6.06%	6.96%	3.25%	9.75%	15.27%	15.81%
FCF Margin	15.84%	7.19%	-2.92%	-5.44%	-0.96%	9.94%

Dividends

Chart

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 4, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Dividend Per Share Dividend Per Share Growth	0.190	0.190	0.110	0.380	0.610	0.490
Dividend Per Share Growth	72.73%	72.73%	-71.05%	-37.70%	24.49%	19.51%
Dividend Yield	0.54%	0.44%	0.22%	0.57%	0.46%	0.32%

Valuation

Chart

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 4, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
PE Ratio	74.99	71.54	140.10	54.41	67.03	95.28
Forward PE	40.91	38.61	34.88	29.56	51.50	90.88
P/FCF Ratio	28.75	69.24	-	-	-	151.56
PS Ratio	4.56	4.98	4.55	5.31	10.23	15.07

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Sep 3, 2026

Data Sources Report a data error